 |
PDBsum entry 2ld1
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metal binding protein
|
PDB id
|
|
|
|
2ld1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Metal binding protein
|
 |
|
Title:
|
 |
Structures and chemical shift assignments for the add domain of the atrx protein
|
|
Structure:
|
 |
Transcriptional regulator atrx. Chain: a. Fragment: add domain, residues 159-296. Synonym: atp-dependent helicase atrx, x-linked helicase ii, x-linked nuclear protein, xnp, znf-hx. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: atrx, rad54l, xh2. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
NMR struc:
|
 |
34 models
|
 |
|
Authors:
|
 |
D.Neuhaus,J.Yang
|
|
Key ref:
|
 |
A.Argentaro
et al.
(2007).
Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX.
Proc Natl Acad Sci U S A,
104,
11939-11944.
PubMed id:
|
 |
|
Date:
|
 |
|
13-May-11
|
Release date:
|
08-Jun-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P46100
(ATRX_HUMAN) -
Transcriptional regulator ATRX from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2492 a.a.
142 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
*
PDB and UniProt seqs differ
at 5 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.6.4.12
- Dna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Proc Natl Acad Sci U S A
104:11939-11944
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX.
|
|
A.Argentaro,
J.C.Yang,
L.Chapman,
M.S.Kowalczyk,
R.J.Gibbons,
D.R.Higgs,
D.Neuhaus,
D.Rhodes.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The chromatin-associated protein ATRX was originally identified because
mutations in the ATRX gene cause a severe form of syndromal X-linked mental
retardation associated with alpha-thalassemia. Half of all of the
disease-associated missense mutations cluster in a cysteine-rich region in the N
terminus of ATRX. This region was named the ATRX-DNMT3-DNMT3L (ADD) domain,
based on sequence homology with a family of DNA methyltransferases. Here, we
report the solution structure of the ADD domain of ATRX, which consists of an
N-terminal GATA-like zinc finger, a plant homeodomain finger, and a long
C-terminal alpha-helix that pack together to form a single globular domain.
Interestingly, the alpha-helix of the GATA-like finger is exposed and highly
basic, suggesting a DNA-binding function for ATRX. The disease-causing mutations
fall into two groups: the majority affect buried residues and hence affect the
structural integrity of the ADD domain; another group affects a cluster of
surface residues, and these are likely to perturb a potential protein
interaction site. The effects of individual point mutations on the folding state
and stability of the ADD domain correlate well with the levels of mutant ATRX
protein in patients, providing insights into the molecular pathophysiology of
ATR-X syndrome.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Dhayalan,
R.Tamas,
I.Bock,
A.Tattermusch,
E.Dimitrova,
S.Kudithipudi,
S.Ragozin,
and
A.Jeltsch
(2011).
The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.
|
| |
Hum Mol Genet,
20,
2195-2203.
|
 |
|
|
|
|
 |
M.Mitson,
L.A.Kelley,
M.J.Sternberg,
D.R.Higgs,
and
R.J.Gibbons
(2011).
Functional significance of mutations in the Snf2 domain of ATRX.
|
| |
Hum Mol Genet,
20,
2603-2610.
|
 |
|
|
|
|
 |
S.Bagheri-Fam,
A.Argentaro,
T.Svingen,
A.N.Combes,
A.H.Sinclair,
P.Koopman,
and
V.R.Harley
(2011).
Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome.
|
| |
Hum Mol Genet,
20,
2213-2224.
|
 |
|
|
|
|
 |
S.Eustermann,
J.C.Yang,
M.J.Law,
R.Amos,
L.M.Chapman,
C.Jelinska,
D.Garrick,
D.Clynes,
R.J.Gibbons,
D.Rhodes,
D.R.Higgs,
and
D.Neuhaus
(2011).
Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin.
|
| |
Nat Struct Mol Biol,
18,
777-782.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Iwase,
B.Xiang,
S.Ghosh,
T.Ren,
P.W.Lewis,
J.C.Cochrane,
C.D.Allis,
D.J.Picketts,
D.J.Patel,
H.Li,
and
Y.Shi
(2011).
ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome.
|
| |
Nat Struct Mol Biol,
18,
769-776.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Hashimoto,
P.M.Vertino,
and
X.Cheng
(2010).
Molecular coupling of DNA methylation and histone methylation.
|
| |
Epigenomics,
2,
657-669.
|
 |
|
|
|
|
 |
I.Whitehouse,
and
T.Owen-Hughes
(2010).
ATRX: Put me on repeat.
|
| |
Cell,
143,
335-336.
|
 |
|
|
|
|
 |
L.H.Wong,
J.D.McGhie,
M.Sim,
M.A.Anderson,
S.Ahn,
R.D.Hannan,
A.J.George,
K.A.Morgan,
J.R.Mann,
and
K.H.Choo
(2010).
ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.
|
| |
Genome Res,
20,
351-360.
|
 |
|
|
|
|
 |
M.J.Law,
K.M.Lower,
H.P.Voon,
J.R.Hughes,
D.Garrick,
V.Viprakasit,
M.Mitson,
M.De Gobbi,
M.Marra,
A.Morris,
A.Abbott,
S.P.Wilder,
S.Taylor,
G.M.Santos,
J.Cross,
H.Ayyub,
S.Jones,
J.Ragoussis,
D.Rhodes,
I.Dunham,
D.R.Higgs,
and
R.J.Gibbons
(2010).
ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.
|
| |
Cell,
143,
367-378.
|
 |
|
|
|
|
 |
V.Barresi,
A.Ragusa,
M.Fichera,
N.Musso,
L.Castiglia,
G.Rappazzo,
S.Travali,
T.Mattina,
C.Romano,
G.Cocchi,
and
D.F.Condorelli
(2010).
Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.
|
| |
BMC Med Genomics,
3,
28.
|
 |
|
|
|
|
 |
V.Lukashchuk,
and
R.D.Everett
(2010).
Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.
|
| |
J Virol,
84,
4026-4040.
|
 |
|
|
|
|
 |
A.Jezela-Stanek,
C.Fisher,
M.Szarras-Czapnik,
D.Olczak-Kowalczyk,
R.J.Gibbons,
J.Słowikowska-Hilczer,
and
M.Krajewska-Walasek
(2009).
X-linked alpha thalassaemia/mental retardation syndrome: a case with gonadal dysgenesis, caused by a novel mutation in ATRX gene.
|
| |
Clin Dysmorphol,
18,
168-171.
|
 |
|
|
|
|
 |
J.Otani,
T.Nankumo,
K.Arita,
S.Inamoto,
M.Ariyoshi,
and
M.Shirakawa
(2009).
Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain.
|
| |
EMBO Rep,
10,
1235-1241.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.G.Urdinguio,
J.V.Sanchez-Mut,
and
M.Esteller
(2009).
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.
|
| |
Lancet Neurol,
8,
1056-1072.
|
 |
|
|
|
|
 |
L.A.Baker,
C.D.Allis,
and
G.G.Wang
(2008).
PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.
|
| |
Mutat Res,
647,
3.
|
 |
|
|
|
|
 |
R.J.Gibbons,
T.Wada,
C.A.Fisher,
N.Malik,
M.J.Mitson,
D.P.Steensma,
A.Fryer,
D.R.Goudie,
I.D.Krantz,
and
J.Traeger-Synodinos
(2008).
Mutations in the chromatin-associated protein ATRX.
|
| |
Hum Mutat,
29,
796-802.
|
 |
|
|
|
|
 |
V.Lukashchuk,
S.McFarlane,
R.D.Everett,
and
C.M.Preston
(2008).
Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection.
|
| |
J Virol,
82,
12543-12554.
|
 |
|
|
|
|
 |
S.D.Taverna,
H.Li,
A.J.Ruthenburg,
C.D.Allis,
and
D.J.Patel
(2007).
How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers.
|
| |
Nat Struct Mol Biol,
14,
1025-1040.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |